Long-term neurodevelopmental follow-up of children exposed to pravastatin in utero

Preeclampsia, especially before term, increases the risk of child neurodevelopmental adverse outcomes. Biological plausibility, preclinical studies, and pilot clinical trials conducted by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Obstetric-Fetal Pharmacology Research Centers Network support the safety and use of pravastatin to prevent preeclampsia.
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Original Research Source Type: research